\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ vitals\\ are\\ normal\\.\ \(0\)\
\-\ gen\\:\\ thin\\ white\\ male\\.\\ non\\ toxic\\ appearing\\.\\ \ \(0\)\
\-\ chest\\/heent\\:\\ axillary\\ adenopathy\\.\\ lungs\\ are\\ clear\\.\ \(0\)\
\-\ labs\\:\\ chem\\ 7\\/ua\\ normal\\.\\ \\ cbc\\ shows\\ lymphocytosis\\ with\\ reed\\ sternberg\\ cells\\.\ \(0\)\
\-\ radiation\\ and\\ chemotherapy\ \(19\)\
\-\ anterior\\ mediastinal\\ mass\\.\ \(8\)\
\-\ hodgkin\\'s\\ lymphoma\ \(0\)\
\-\ hodgkin\\'s\\ lymphoma\ \(0\)\
\-\ non\\ hodgkin\\'s\\ lymphoma\ \(0\)\
\-\ thymoma\ \(20\)\
\-\ thymolipoma\ \(2\)\
\-\ benign\\ thymic\\ hyperplasia\ \(0\)\
\-\ thyroid\\ masses\ \(1\)\
\-\ germ\\ cell\\ tumors\\.\ \(2\)\
\-\ 32\\ year\\ old\\ active\\ duty\\ soldier\\ who\\ presents\\ with\\ increasing\\ shortness\\ of\\ breath\\ and\\ low\\ grade\\ fever\\.\ \(1\)\
\-\ the\\ cell\\ of\\ orgin\\ is\\ the\\ antigen\\ presenting\\ interdigitating\\ cells\\ in\\ the\\ paracortical\\ regions\\ of\\ the\\ lymph\\ node\\.\\ the\\ pathological\\ diagnosis\\ is\\ based\\ on\\ the\\ presence\\ of\\ reed\\ sternberg\\ cells\\.\\ approximately\\ 90\\%\\ originate\\ in\\ the\\ lymph\\ nodes\\ and\\ 10\\%\\ originate\\ in\\ extranodal\\ lymphoid\\ tissue\\ or\\ parenchymal\\ organs\\.\\ \ \(0\)\
\-\ types\\ of\\ hodgkins\\'s\\ lymphoma\\/prognosis\\ best\\ to\\ worst\\.\\ lymphocyte\\ predominant\\ \\>\\ nodular\\ sclerosiing\\ \\>\\ mixed\\ cellularity\\ \\>\\ lymphocyte\\ depleted\\.\\ the\\ most\\ common\\ type\\ is\\ nodular\\ sclerosing\\.\\ \ \(0\)\
\-\ incidence\\ is\\ 1\\:50\\,000\\.\\ bimodal\\ age\\ distribution\\ with\\ peaks\\ in\\ 30\\'s\\ and\\ 70\\'s\\ years\\ of\\ age\\.\\ \ \(0\)\
\-\ radiographic\\ features\\.\\ \ \(0\)\
\-\ superior\\ and\\ anterior\\ mediastinal\\ nodal\\ involvement\\-\\ 95\\%\\.\\ \\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ contiguous\\ progression\\ from\\ one\\ lymph\\ node\\ group\\ to\\ the\\ next\\.\\ \ \(0\)\
\-\ lung\\ involvement\\ \\-\\ 15\\%\\ \\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ pleural\\ effusions\\ \\-\\ 15\\%\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hodgkin\\:\\ 0\\.23776236942499432\ \(0\)\
\-\ sternberg\\:\\ 0\\.22324107952948608\ \(0\)\
\-\ lymphocyte\\:\\ 0\\.1994249530108594\ \(0\)\
\-\ originate\\:\\ 0\\.1952314599287481\ \(0\)\
\-\ reed\\:\\ 0\\.19159889099137384\ \(0\)\
\-\ lymphoma\\:\\ 0\\.18483943094343608\ \(0\)\
\-\ lymph\\:\\ 0\\.18100505894322327\ \(0\)\
\-\ cells\\:\\ 0\\.17934680787575472\ \(0\)\
\-\ the\\:\\ 0\\.13933877630217886\ \(0\)\
\-\ node\\:\\ 0\\.13338083666985692\ \(0\)\
\-\ mediastinal\\:\\ 0\\.1253058812654722\ \(0\)\
\-\ lymphocytosis\\:\\ 0\\.12408386087893741\ \(0\)\
\-\ orgin\\:\\ 0\\.12408386087893741\ \(0\)\
\-\ paracortical\\:\\ 0\\.12408386087893741\ \(0\)\
\-\ sclerosiing\\:\\ 0\\.12408386087893741\ \(0\)\
\-\ nodular\\:\\ 0\\.12357807164558361\ \(0\)\
\-\ interdigitating\\:\\ 0\\.11856875342759671\ \(0\)\
\-\ thymolipoma\\:\\ 0\\.1146557224178539\ \(0\)\
\-\ extranodal\\:\\ 0\\.1146557224178539\ \(0\)\
\-\ involvement\\:\\ 0\\.1123163331564583\ \(0\)\
\-\ depleted\\:\\ 0\\.11162053976474304\ \(0\)\
\-\ bimodal\\:\\ 0\\.10522758395677043\ \(0\)\
\-\ 15\\:\\ 0\\.10486166062126111\ \(0\)\
\-\ peaks\\:\\ 0\\.10219240130365954\ \(0\)\
\-\ cellularity\\:\\ 0\\.10089599904285827\ \(0\)\
\-\ age\\:\\ 0\\.09742397953878673\ \(0\)\
\-\ antigen\\:\\ 0\\.09497483371817896\ \(0\)\
\-\ lymphoid\\:\\ 0\\.09497483371817896\ \(0\)\
\-\ hodgkins\\:\\ 0\\.09497483371817896\ \(0\)\
\-\ of\\:\\ 0\\.0911045282067971\ \(0\)\
\-\ nodal\\:\\ 0\\.08972908018946517\ \(0\)\
\-\ cell\\:\\ 0\\.08877050978494834\ \(0\)\
\-\ chem\\:\\ 0\\.08868226160274828\ \(0\)\
\-\ worst\\:\\ 0\\.08868226160274828\ \(0\)\
\-\ predominant\\:\\ 0\\.08724915539123533\ \(0\)\
\-\ thymic\\:\\ 0\\.08680315056230446\ \(0\)\
\-\ anterior\\:\\ 0\\.08664383468387386\ \(0\)\
\-\ soldier\\:\\ 0\\.08637130703460343\ \(0\)\
\-\ is\\:\\ 0\\.08499457782353503\ \(0\)\
\-\ thymoma\\:\\ 0\\.08476923059300549\ \(0\)\
\-\ sclerosing\\:\\ 0\\.08173404793989461\ \(0\)\
\-\ pathological\\:\\ 0\\.0808561995832627\ \(0\)\
\-\ and\\:\\ 0\\.08016547930694685\ \(0\)\
\-\ organs\\:\\ 0\\.08003158780575474\ \(0\)\
\-\ toxic\\:\\ 0\\.07925412314166477\ \(0\)\
\-\ in\\:\\ 0\\.07720784366657454\ \(0\)\
\-\ gen\\:\\ 0\\.07652461466935055\ \(0\)\
\-\ axillary\\:\\ 0\\.07632007053510313\ \(0\)\
\-\ group\\:\\ 0\\.07373901569032405\ \(0\)\
\-\ non\\:\\ 0\\.07363008747763422\ \(0\)\
\-\ duty\\:\\ 0\\.07357211876694267\ \(0\)\
\-\ 95\\:\\ 0\\.07357211876694267\ \(0\)\
\-\ effusions\\:\\ 0\\.07261158365960778\ \(0\)\
\-\ germ\\:\\ 0\\.07245788791580242\ \(0\)\
\-\ next\\:\\ 0\\.07245788791580242\ \(0\)\
\-\ types\\:\\ 0\\.07215561039593053\ \(0\)\
\-\ progression\\:\\ 0\\.07114759904981069\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.07073745957746093\ \(0\)\
\-\ parenchymal\\:\\ 0\\.06970062039588912\ \(0\)\
\-\ vitals\\:\\ 0\\.0685067028036156\ \(0\)\
\-\ incidence\\:\\ 0\\.0667908020274704\ \(0\)\
\-\ regions\\:\\ 0\\.06659077006065615\ \(0\)\
\-\ 32\\:\\ 0\\.06649184650751798\ \(0\)\
\-\ nodes\\:\\ 0\\.06591295367083849\ \(0\)\
\-\ distribution\\:\\ 0\\.06581882230136808\ \(0\)\
\-\ adenopathy\\:\\ 0\\.06526731722030107\ \(0\)\
\-\ cbc\\:\\ 0\\.06473730489837805\ \(0\)\
\-\ mixed\\:\\ 0\\.06422717278906775\ \(0\)\
\-\ 70\\:\\ 0\\.06406129355515619\ \(0\)\
\-\ normal\\:\\ 0\\.06335923915853876\ \(0\)\
\-\ best\\:\\ 0\\.06243176618879674\ \(0\)\
\-\ features\\:\\ 0\\.06243176618879674\ \(0\)\
\-\ shortness\\:\\ 0\\.06221413068818491\ \(0\)\
\-\ appearing\\:\\ 0\\.061999922661095705\ \(0\)\
\-\ 90\\:\\ 0\\.061999922661095705\ \(0\)\
\-\ increasing\\:\\ 0\\.06110879765274829\ \(0\)\
\-\ thyroid\\:\\ 0\\.060976739056177266\ \(0\)\
\-\ presenting\\:\\ 0\\.06078102447667197\ \(0\)\
\-\ thin\\:\\ 0\\.06039784621949778\ \(0\)\
\-\ are\\:\\ 0\\.05888401796009991\ \(0\)\
\-\ active\\:\\ 0\\.05761691262504886\ \(0\)\
\-\ radiographic\\:\\ 0\\.05756568119498179\ \(0\)\
\-\ lungs\\:\\ 0\\.05726227987384496\ \(0\)\
\-\ tumors\\:\\ 0\\.05706370804643448\ \(0\)\
\-\ breath\\:\\ 0\\.056867993466929175\ \(0\)\
\-\ clear\\:\\ 0\\.056250697061614896\ \(0\)\
\-\ based\\:\\ 0\\.05620435313738647\ \(0\)\
\-\ grade\\:\\ 0\\.055794213665036715\ \(0\)\
\-\ presence\\:\\ 0\\.05574939672629466\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.05509428157948333\ \(0\)\
\-\ labs\\:\\ 0\\.05375530673744078\ \(0\)\
\-\ benign\\:\\ 0\\.05329933347376354\ \(0\)\
\-\ 30\\:\\ 0\\.052930694959932814\ \(0\)\
\-\ masses\\:\\ 0\\.052822023847118954\ \(0\)\
\-\ fever\\:\\ 0\\.05260725209130213\ \(0\)\
\-\ type\\:\\ 0\\.05205057374364108\ \(0\)\
\-\ radiation\\:\\ 0\\.051417811812382516\ \(0\)\
\-\ white\\:\\ 0\\.0511919145676232\ \(0\)\
\-\ approximately\\:\\ 0\\.049508293672786724\ \(0\)\
\-\ years\\:\\ 0\\.047561846214611646\ \(0\)\
\-\ with\\:\\ 0\\.045579481570345824\ \(0\)\
\-\ shows\\:\\ 0\\.04553882304429533\ \(0\)\
\-\ 10\\:\\ 0\\.045370895866900754\ \(0\)\
\-\ low\\:\\ 0\\.04452176284856625\ \(0\)\
\-\ one\\:\\ 0\\.04442411757206172\ \(0\)\
\-\ common\\:\\ 0\\.04400261563506636\ \(0\)\
\-\ who\\:\\ 0\\.04388989182469969\ \(0\)\
\-\ physical\\:\\ 0\\.04207126884855342\ \(0\)\
\-\ tissue\\:\\ 0\\.04070214866849326\ \(0\)\
\-\ most\\:\\ 0\\.04038036760918404\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04022228742036509\ \(0\)\
\-\ exam\\:\\ 0\\.039059020923318366\ \(0\)\
\-\ to\\:\\ 0\\.0387948701035902\ \(0\)\
\-\ presents\\:\\ 0\\.0373249633318287\ \(0\)\
\-\ male\\:\\ 0\\.03454620852105912\ \(0\)\
\-\ from\\:\\ 0\\.03081559747137792\ \(0\)\
\-\ mass\\:\\ 0\\.02963744235076452\ \(0\)\
\-\ or\\:\\ 0\\.02699230110958147\ \(0\)\
\-\ year\\:\\ 0\\.023911818200396333\ \(0\)\
\-\ on\\:\\ 0\\.023433617471806615\ \(0\)\
\-\ old\\:\\ 0\\.02296362275366432\ \(0\)\
